youngae kang

Department of Internal Medicine

EmailMDKANG@YUHS.AC

2180 Citations
24 h-Index

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where youngae kang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

9 Similar Profiles

Tuberculosis Medicine & Life Sciences

Korea Medicine & Life Sciences

Latent Tuberculosis Medicine & Life Sciences

Lung Medicine & Life Sciences

Tuberculin Test Medicine & Life Sciences

Multidrug-Resistant Tuberculosis Medicine & Life Sciences

Pneumonia Medicine & Life Sciences

Skin Tests Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

2180 Citations
24 h-Index
127 Article
4 Review article
2 Comment/debate
1 Editorial

1 Citation (Scopus)

Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): Study protocol for a phase II/III, multicenter, randomized, open-label clinical trial

Lee, M., Mok, J., Kim, D. K., Shim, T. S., Koh, W. J., Jeon, D., Lee, T., Lee, S. H., Kim, J. S., Park, J. S., Lee, J. Y., Kim, S. Y., Lee, J. H., Jo, K. W., Jhun, B. W., Kang, Y. A., Ahn, J. H., Kim, C. K., Shin, S., Song, T. & 8 others, Shin, S. J., Kim, Y. R., Ahn, H., Hahn, S., Won, H. J., Jang, J. Y., Cho, S. N. & Yim, J. J., 2019 Jan 16, In : Trials. 20, 1, 57.

Research output: Contribution to journal › Article

Open Access

Linezolid

Pyrazinamide

Multidrug-Resistant Tuberculosis

Levofloxacin

Fluoroquinolones

Evaluation and treatment of latent tuberculosis infection among healthcare workers in Korea: A multicentre cohort analysis

Han, S. S., Lee, S. J., Yim, J. J., Song, J. H., Lee, E. H. & Kang, Y. A., 2019 Jan 1, In : PloS one. 14, 9, e0222810.

Research output: Contribution to journal › Article

Open Access

Latent Tuberculosis

health care workers

Rifampin

Korea

tuberculosis

1 Citation (Scopus)

Improved Fluoroquinolone-Resistant and Extensively Drug-Resistant Tuberculosis Treatment Outcomes

Lee, E. H., Yong, S. H., Leem, A. Y., Lee, S. H., Kim, S. Y., Chung, K. S., Jung, J. Y., Park, M. S., Kim, Y. S., Chang, J. & Kang, Y. A., 2019 Apr 1, In : Open Forum Infectious Diseases. 6, 4

Research output: Contribution to journal › Article

Open Access

Extensively Drug-Resistant Tuberculosis

Multidrug-Resistant Tuberculosis

Fluoroquinolones

Linezolid

bedaquiline

In vitro mycobacterial growth inhibition in South Korean adults with latent TB infection

Lee, H., Kim, J., Kang, Y. A., Kim, D. R., Sim, B., Zelmer, A., Fletcher, H. A., Dockrell, H. M., Smith, S. G. & Cho, S. N., 2019 Jan 1, In : Frontiers in Immunology. 10, APR, 896.

Research output: Contribution to journal › Article

Open Access

Growth

Infection

Bacillus

Mycobacterium Infections

Staining and Labeling

1 Citation (Scopus)

Mortality of patients with chronic obstructive pulmonary disease: A nationwide population-based cohort study

Park, S. C., Kim, D. W., Park, E. C., Shin, C. S., Rhee, C. K., Kang, Y. A. & Kim, Y. S., 2019 Nov, In : Korean Journal of Internal Medicine. 34, 6, p. 1272-1278 7 p.

Research output: Contribution to journal › Article

Open Access

Chronic Obstructive Pulmonary Disease

Cohort Studies

Hyeyoung Lee, Sang-Jun Ha & youngae kang

15/1/6

3 items of Media coverage

Press/Media: Press / Media